The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart
Abstract
Background Tumor necrosis factor-α (TNF-α) is a proinflammatory cytokine that produces negative inotropic effects in the heart. Recently, elevated levels of TNF-α have been reported in patients with advanced congestive heart failure. Although TNF-α is thought to exert its deleterious effects by binding to two cell surface receptors, TNFR1 and TNFR2, the level of expression and regulation of TNF receptors in the heart in cardiac disease states is not known. Methods and Results We examined mRNA and protein levels for TNFR1, TNFR2, and TNF-α in explanted hearts from organ donors as well as in patients with end-stage dilated cardiomyopathy (DCM) and ischemic heart disease (IHD). Northern blot analysis revealed that mRNA for TNFR1 and TNFR2 was present in nonfailing, DCM, and IHD hearts. TNFR1 and TNFR2 receptor protein levels, as measured by ELISA, were decreased 60% in DCM and IHD patients compared with nonfailing hearts ( P <.005). To determine a potential mechanism for the decrease in TNF receptor expression, we measured levels of circulating soluble TNF receptors (sTNFRs) in DCM and IHD patients. This analysis showed that there was a significant one-and-a-half to threefold increase in sTNFRs in DCM ( P <.03) and IHD patients ( P <.001). Another important finding was that TNF-α mRNA and TNF-α protein were present in the explanted hearts from DCM and IHD patients but not in nonfailing hearts. Conclusions In summary, the results of this study constitute the initial demonstration that TNF receptor proteins are dynamically regulated in patients with advanced congestive heart failure. Moreover, the observation that failing hearts express elevated levels of TNF-α suggests that overexpression of this cytokine may be one of several different maladaptive mechanisms responsible for the progressive cardiac decompensation that occurs in advanced heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582
Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric Oxide
Finkel, M. S., Oddis, C. V., Jacob, T. D., Watkins, S. C., Hattler, B. G., & Simmons, R. L. (1992) · Science · doi:10.1126/science.1631560 · Cited by 1,628
The Cardiovascular Response of Normal Humans to the Administration of Endotoxin
Suffredini, A. F., Fromm, R. E., Parker, M. M., Brenner, M., Kovacs, J. A., Wesley, R. A., & Parrillo, J. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210503 · Cited by 1,102
Yokoyama, T., Vaca, L., Rossen, R. D., Durante, W., Hazarika, P., & Mann, D. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116834 · Cited by 717
Self-citationIncreased circulating cytokines in patients with myocarditis and cardiomyopathy.
Matsumori, A., Yamada, T., Suzuki, H., Matoba, Y., & Sasayama, S. (1994) · Heart · doi:10.1136/hrt.72.6.561 · Cited by 524
Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness.
Gulick, T., Chung, M. K., Pieper, S. J., Lange, L. G., & Schreiner, G. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6753 · Cited by 496
Engelmann, H., Aderka, D., Rubinstein, M., Rotman, D., & Wallach, D. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80162-4 · Cited by 440
Kapadia, S., Lee, J., Torre-Amione, G., Birdsall, H. H., Ma, T. S., & Mann, D. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118090 · Cited by 437
Self-citationBasic Mechanisms in Congestive Heart Failure
Mann, D. L., & Young, J. B. (1994) · Chest · doi:10.1378/chest.105.3.897 · Cited by 358
Self-citationMcMurray, J., Abdullah, I., Dargie, H. J., & Shapiro, D. (1991) · Heart · doi:10.1136/hrt.66.5.356 · Cited by 344
Expression and Functional Significance of Tumor Necrosis Factor Receptors in Human Myocardium
Torre-Amione, G., Kapadia, S., Lee, J., Bies, R. D., Lebovitz, R., & Mann, D. L. (1995) · Circulation · doi:10.1161/01.cir.92.6.1487 · Cited by 340
Self-citationKull, F. C., Jacobs, S., & Cuatrecasas, P. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.17.5756 · Cited by 281
A human inhibitor of tumor necrosis factor alpha.
Seckinger, P., Isaaz, S., & Dayer, J. M. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.4.1511 · Cited by 255
The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia.
Giroir, B. P., Johnson, J. H., Brown, T., Allen, G. L., & Beutler, B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115939 · Cited by 224
Katz, S. D., Rao, R., Berman, J. W., Schwarz, M., Demopoulos, L., Bijou, R., & LeJemtel, T. H. (1994) · Circulation · doi:10.1161/01.cir.90.1.12 · Cited by 217
Chung, M. K., Gulick, T. S., Rotondo, R. E., Schreiner, G. F., & Lange, L. G. (1990) · Circulation Research · doi:10.1161/01.res.67.3.753 · Cited by 214
Millar, A. B., Singer, M., Meager, A., Foley, N. M., Johnson, N. M., & Rook, G. A. W. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90772-1 · Cited by 199
HEGEWISCH, S. (1990) · The Lancet · doi:10.1016/0140-6736(90)90115-l · Cited by 186
Tumour necrosis factor alpha in severe congestive cardiac failure.
Dutka, D. P., Elborn, J. S., Delamere, F., Shale, D. J., & Morris, G. K. (1993) · Heart · doi:10.1136/hrt.70.2.141 · Cited by 168
Peetre, C., Gullberg, U., Nilsson, E., & Olsson, I. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112764 · Cited by 158
Brakebusch, C., Nophar, Y., Kemper, O., Engelmann, H., & Wallach, D. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05133.x · Cited by 143
Ding, A. H., Sánchez, E., Srimal, S., & Nathan, C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84941-4 · Cited by 125
A tumor necrosis factor binding protein is present in human biological fluids
Peetre, C., Thysell, H., GRUBB, A. O., & Olsson, I. (1988) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1988.tb00220.x · Cited by 115
Measuring circulating cytokines
Cannon, J. G., Nerad, J. L., Poutsiaka, D. D., & Dinarello, C. A. (1993) · Journal of Applied Physiology · doi:10.1152/jappl.1993.75.4.1897 · Cited by 113
Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock
Giroir, B. P., Horton, J. W., White, D. J., McIntyre, K., & Lin, C. Q. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.267.1.h118 · Cited by 110
Rubin, B. Y., Anderson, S. L., Sullivan, S. A., Williamson, B., Carswell, E. A., & Old, L. J. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.164.4.1350 · Cited by 108
Scheurich, P., Üçer, U., Krönke, M., & Pfizenmaier, K. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910380120 · Cited by 106
Wiedermann, C. J., Beimpold, H., Herold, M., Knapp, E., & Braunsteiner, H. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90776-w · Cited by 87
Aggarwal, B., & Eessalu, T. E. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49277-0 · Cited by 83
Stauber, G. B., Aiyer, R. A., & Aggarwal, B. B. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37395-2 · Cited by 74
The Search for the Ideal Positive Inotropic Agent
Packer, M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307153290310 · Cited by 74
Pennica, D., Lam, V. T., Mize, N. K., Weber, R. F., Lewis, M., FENDLY, B. M., Lipari, M. T., & Goeddel, D. V. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36813-9 · Cited by 67
Tumor necrosis factor: Molecular and cellular biology and clinical relevance
(1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)90011-x · Cited by 45
Michishita, M., Yoshida, Y., Uchino, H., & Nagata, K. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38952-5 · Cited by 42
Pitfalls in Measuring Cytokines
Kapadia, S. R., Torre‐Amione, G., & Mann, D. L. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-2-199407150-00016 · Cited by 29
Self-citationAggarwal, B. B., Graff, K. L., Samal, B. B., Higuchi, M., & Liao, W. S. ‐. (1993) · PubMed · Cited by 25
Pitfalls in Measuring Cytokines
Case, L. C., Balk, R., & Bone, R. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-2-199407150-00017 · Cited by 5
Cited by
The pathogenesis of cardiac fibrosis
Kong, P., Christia, P., & Frangogiannis, N. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1349-6 · Cited by 1,567
Molecular Mechanisms of Myocardial Remodeling
SWYNGHEDAUW, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.215 · Cited by 1,460
Torre-Amione, G., Kapadia, S., Benedict, C., Oral, H., Young, J. B., & Mann, D. L. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00589-7 · Cited by 1,211
Self-citationInflammatory Mediators and the Failing Heart: Past, Present, and the Foreseeable Future
Mann, D. L. (2002) · Circulation Research · doi:10.1161/01.res.0000043825.01705.1b · Cited by 988
Self-citationSchleithoff, S. S., Zittermann, A., Tenderich, G., Berthold, H. K., Stehle, P., & Koerfer, R. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.4.754 · Cited by 925
Metadata
- Authors
- Torre-Amione, G., Kapadia, S., Lee, J., Durand, J.-B., Bies, R. D., Young, J. B., & Mann, D. L.
- Venue
- Circulation
- Published
- 1996-02-15
- Volume
- 93
- Issue
- 4
- Pages
- 704-711
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2015639803
- Cited by
- 989
- References
- 37
- FWCI
- 36.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.